| |
| |
|
| Insider
Information: |
Samaha Eli |
| Relationship: |
10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
64,948 |
|
|
Indirect Shares
|
19,985,460 |
|
|
| Direct
Value |
$457,883 |
|
|
|
Indirect Value
|
$213,683,245 |
|
|
| Total
Shares |
20,050,408 |
|
|
| Total
Value |
$214,141,128 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stagwell Inc |
STGW |
Director |
2023-06-14 |
64,948 |
2023-06-14 |
7,147,662 |
Premium* |
|
|
Pfsweb Inc |
PFSW |
10% Owner |
|
0 |
2022-12-29 |
2,633,189 |
Premium* |
|
|
Theravance Biopharma, Inc. |
TBPH |
10% Owner |
|
0 |
2024-05-01 |
8,511,350 |
Premium* |
|
|
Synovus Financial Corp |
SNV |
10% Owner |
|
0 |
2023-10-20 |
1,693,259 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
41 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SNV |
Synovus Financial Corp |
10% Owner |
– – • |
2023-10-10 |
4 |
B |
$21.50 |
$23,048 |
I/I |
1,072 |
1,687,304 |
1.5 |
% |
|
| SNV |
Synovus Financial Corp |
10% Owner |
– – • |
2023-10-11 |
4 |
B |
$21.50 |
$18,942 |
I/I |
881 |
1,688,185 |
1.5 |
% |
|
| SNV |
Synovus Financial Corp |
10% Owner |
– – • |
2023-10-12 |
4 |
B |
$21.50 |
$5,053 |
I/I |
235 |
1,688,420 |
1.5 |
% |
|
| SNV |
Synovus Financial Corp |
10% Owner |
– – • |
2023-10-13 |
4 |
B |
$21.50 |
$91,999 |
I/I |
4,279 |
1,692,699 |
1.5 |
% |
|
| SNV |
Synovus Financial Corp |
10% Owner |
– – • |
2023-10-20 |
4 |
B |
$21.35 |
$11,956 |
I/I |
560 |
1,693,259 |
1.5 |
% |
|
| TBPH |
Theravance Biopharma, Inc... |
10% Owner |
– – • |
2024-05-01 |
4 |
B |
$8.75 |
$13,117,335 |
I/I |
1,499,124 |
8,511,350 |
1.5 |
% |
|
| STGW |
Stagwell Inc |
Director |
– • – |
2021-08-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,010,249 |
|
% |
|
| STGW |
Stagwell Inc |
Director |
– • – |
2021-08-09 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| STGW |
Stagwell Inc |
Director |
– • – |
2021-12-03 |
4 |
B |
$7.85 |
$20,920 |
I/I |
2,665 |
5,462,914 |
2.1 |
% |
|
| STGW |
Stagwell Inc |
Director |
– • – |
2021-12-06 |
4 |
B |
$8.14 |
$2,363,009 |
I/I |
290,296 |
5,753,210 |
2.1 |
% |
|
| STGW |
Stagwell Inc |
Director |
– • – |
2022-05-10 |
4 |
B |
$6.79 |
$255,450 |
I/I |
37,606 |
5,790,816 |
2.1 |
% |
|
| STGW |
Stagwell Inc |
Director |
– • – |
2022-05-11 |
4 |
B |
$6.91 |
$3,849,198 |
I/I |
556,846 |
6,347,662 |
2.1 |
% |
|
| STGW |
Stagwell Inc |
Director |
– • – |
2022-05-12 |
4 |
B |
$6.90 |
$344,790 |
I/I |
50,000 |
6,397,662 |
2.1 |
% |
|
| STGW |
Stagwell Inc |
Director |
– • – |
2022-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
21,008 |
46,008 |
0 |
- |
|
| STGW |
Stagwell Inc |
Director |
– • – |
2023-03-10 |
4 |
B |
$6.75 |
$5,062,500 |
I/I |
750,000 |
7,147,662 |
2.1 |
% |
|
| STGW |
Stagwell Inc |
Director |
– • – |
2023-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
18,940 |
64,948 |
0 |
- |
|
41 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
